ARQT Arcutis Biotherapeutics Inc tops Q4 2025 EPS estimates on 91 percent year over year revenue growth shares slip 203 percent Fulgent Genetics FLGT Stock Pre Market Momentum Building 20260418 Is Core Sci CORZ stock a viable buying opportunity Q4 2025 EPS Exceeds Expectations Broadway Fin BYFC Stock Fair Value Trend Strengthens 20260415 ASIC Ategrity Specialty Insurance Company Holdings reports robust Q4 2025 earnings with 299 percent EPS beat and 234 percent annual revenue growth Quantum QNC Stock Price Action Investor Interest 20260415 Is JinkoSolar JKS stock losing bullish momentum Consolidates 20260418 X4 Pharmaceuticals XFOR Stock Next Quarter Institutional Demand 20260418 MT Arcelor Mittal NY Registry Shares NEW posts 53 percent Q4 2025 EPS beat edges down 077 percent on mild revenue decline Rumble RUMBW Stock Under Pressure 700 20260416 Market Wrap Technology leads broad market gains while consumer stocks lag lululemon LULU Market Performance lululemon athletica inc beats EPS on strong sales